Aptevo Therapeutics Inc. (APVO)
NASDAQ: APVO · Real-Time Price · USD
3.470
+0.060 (1.76%)
At close: Feb 21, 2025, 4:00 PM
3.310
-0.160 (-4.61%)
After-hours: Feb 21, 2025, 5:57 PM EST

Aptevo Therapeutics Stock Forecast

APVO's stock price has decreased by -98.52% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 1 analyst with a 12-month price forecast for Aptevo Therapeutics stock has a target of 296, which predicts an increase of 8,430.26% from the current stock price of 3.47.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $296 $296 $296 $296
Change +8430.3% +8430.3% +8430.3% +8430.3%
* Price targets were last updated on Sep 23, 2024.

Analyst Ratings

According to 1 stock analyst, the rating for Aptevo Therapeutics is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Sep '24Oct '24Nov '24Dec '24Jan '25Feb '25
Strong Buy 111111
Buy 000000
Hold 000000
Sell 000000
Strong Sell 000000
Total 111111

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Roth MKM
Roth MKM
Strong Buy
Maintains
$555$296
Strong Buy Maintains $555$296 +8,430.26% Sep 23, 2024
Piper Sandler
Piper Sandler
Buy
Maintains
$112,332$32,560
Buy Maintains $112,332$32,560 +938,228.53% May 13, 2022
Roth Capital
Roth Capital
Strong Buy
Maintains
$104,192$81,400
Strong Buy Maintains $104,192$81,400 +2,345,721.33% May 28, 2021
Piper Sandler
Piper Sandler
Buy
Maintains
$52,096$112,332
Buy Maintains $52,096$112,332 +3,237,133.43% Nov 11, 2020
Roth Capital
Roth Capital
Strong Buy
Initiates
$273,504
Strong Buy Initiates $273,504 +7,881,859.65% Apr 11, 2018
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-15.11
from -87.38
EPS Next Year
-13.82
from -15.11
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027
Revenue
4.31M12.29M3.11M----6.87M
Revenue Growth
-185.26%-74.67%-----
EPS
-----87.38-15.11-13.8223.02
EPS Growth
--------
Forward PE
-------0.15
No. Analysts -----333
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20252026202720282029
High n/a n/a 7.1M
Avg n/a n/a 6.9M
Low n/a n/a 6.6M

Revenue Growth

Revenue Growth 20252026202720282029
High - - -
Avg - - -
Low - - -

EPS Forecast

EPS 20252026202720282029
High -15.55 -14.23 23.70
Avg -15.11 -13.82 23.02
Low -14.51 -13.28 22.12

EPS Growth

EPS Growth 20252026202720282029
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.